Noevir Holdings Reports Mixed Financial Results for First Half of Fiscal Year 2025

Noevir Holdings Co., Ltd. ( (JP:4928) ) has issued an announcement.

Noevir Holdings reported its consolidated financial results for the first six months of the fiscal year ending September 30, 2025, showing a slight increase in net sales by 1.3% compared to the previous year. However, the company faced a decline in operating and ordinary income, with operating income dropping by 7.3% and ordinary income by 3.5%. Despite these challenges, net income attributable to owners of the parent increased by 1.7%. The equity ratio also decreased from 69.9% to 66.5%, indicating changes in the company’s financial position. The company maintained its dividend forecast, signaling stability in shareholder returns.

More about Noevir Holdings Co., Ltd.

Noevir Holdings Co., Ltd. is a company listed on the Tokyo Stock Exchange, primarily operating in the cosmetics and pharmaceutical industry. The company focuses on the development and sale of beauty and health products, catering to a diverse market with a range of skincare, makeup, and health supplements.

Average Trading Volume: 63,045

Technical Sentiment Signal: Sell

Current Market Cap: Yen143.1B

Learn more about 4928 stock on TipRanks’ Stock Analysis page.